ADIPOQ and metabolic syndrome: Subsequent studies showed that, in obese subjects, increased plasma 2-AG levels were significantly correlated with markers of metabolic syndrome, such as free fatty acids, triglycerides, HDL cholesterol, and adiponectin, confirming the role of endocannabinoids in this syndrome [62,63].